Vinay Prasad's profile photo

Vinay Prasad

Portland

These posts were issued before my FDA employment and do not necessarily represent the views of the FDA or the United States. The account is now inactive.

Articles

  • 2 weeks ago | sensible-med.com | Vinay Prasad |John Mandrola |Adam Cifu

    The most common question we get asked is: is there a course on how to become better at critically reading medical research. Here it is!This is the fourth of 9 videos that we recorded as part of a course on clinical appraisal, and there will be many more to come. This and future videos will be made available as a thank you to paid subscribers.

  • 3 weeks ago | nature.com | Vinay Prasad

    In a recent News & Views (Prasad, V. Surrogate end points in oncology: the speed–uncertainty trade-off from the patients’ perspective. Nat. Rev. Clin. Oncol. 22, 313–314 (2025))1, I discussed two studies that, using surveys, show that patients with cancer crave information about how long and how well they will live. That is, patients are willing to wait for overall survival (OS) results rather than accepting improvements in progression-free survival (PFS).

  • 3 weeks ago | jamanetwork.com | Vinay Prasad

    Pausing Chikungunya Vaccination and Accelerated Approval On May 9, 2025, the US Food and Drug Administration (FDA) initiated a coordinated action with the Centers for Disease Control and Prevention (CDC) to issue a safety communication recommending a pause in the use of live attenuated chikungunya virus (CHIKV) vaccine (IXCHIQ; Valneva Austria GmbH) for individuals aged 60 years and older while the agencies investigate postmarketing reports of serious adverse events, including neurologic and...

  • 1 month ago | sensible-med.com | Vinay Prasad |Adam Cifu |John Mandrola

    The most common question we get asked is: is there a course on how to become better at critically reading medical research. Here it is!This is the third of 9 videos that we recorded as part of a course on clinical appraisal, and there will be many more to come. This and future videos will be made available as a thank you to paid subscribers.

  • 1 month ago | sensible-med.com | Vinay Prasad |Adam Cifu |John Mandrola

    This is a long one! 83 minutes. This is the second podcast in which we answer questions from a our “ask us anything” post. We recorded this one before our most recent podcast — kind of like Abbey Road and Let it Be — so we were still graced by Vinay’s presence. In fact, we recorded it in his studio. We still have about a half dozen questions to answer; we will cover those on an upcoming podcast. Enjoy.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
293K
Tweets
47K
DMs Open
Yes
No Tweets found.